Education
About Us
Working with TipRanks
Follow Us
3-D Matrix Ltd (DMTRF)
OTHER OTC:DMTRF
DMTRF Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.69 - $1.11
Previous CloseN/A
Volume900.00
Average Volume (3M)0.00
Market Cap
$156.36M
Enterprise Value$23.05B
Total Cash (Recent Filing)$2.07B
Total Debt (Recent Filing)¥3.85B
Price to Earnings (P/E)―
Beta-0.04
Next Earnings
Jun 11, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.06
Shares Outstanding110,293,400
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-1.49
Price to Book (P/B)7.49
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
DMTRF FAQ
What was 3-D Matrix Ltd’s price range in the past 12 months?
3-D Matrix Ltd lowest stock price was $0.69 and its highest was $1.11 in the past 12 months.
What is 3-D Matrix Ltd’s market cap?
3-D Matrix Ltd’s market cap is $156.36M.
When is 3-D Matrix Ltd’s upcoming earnings report date?
3-D Matrix Ltd’s upcoming earnings report date is Jun 11, 2025 which is 35 days ago.
How were 3-D Matrix Ltd’s earnings last quarter?
Currently, no data Available
Is 3-D Matrix Ltd overvalued?
According to Wall Street analysts 3-D Matrix Ltd’s price is currently Overvalued.
Does 3-D Matrix Ltd pay dividends?
3-D Matrix Ltd does not currently pay dividends.
What is 3-D Matrix Ltd’s EPS estimate?
3-D Matrix Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does 3-D Matrix Ltd have?
3-D Matrix Ltd has 110,293,400 shares outstanding.
What happened to 3-D Matrix Ltd’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of 3-D Matrix Ltd?
Currently, no hedge funds are holding shares in DMTRF
Company Description
3-D Matrix Ltd
3-D Matrix, Ltd. develops self-assembling peptide technology. It offers PuraMatrix, a self-assembling peptide hydrogel for use in the fields of regenerative medicine, cell therapy, drug delivery technology, and surgical treatment. The company was founded in 2004 and is based in Tokyo, Japan.
Technical Analysis
Create Medic Co., Ltd.
―
Techno Medica Co., Ltd.
―
Japan Medical Dynamic Marketing, Inc.
―
Colan Totte.Co.,Ltd.
―
Koken Ltd.
―